Document Detail


Influence of erectile dysfunction course on its progress and efficacy of treatment with phosphodiesterase type 5 inhibitors.
MedLine Citation:
PMID:  21163126     Owner:  NLM     Status:  In-Process    
Abstract/OtherAbstract:
BACKGROUND: Erectile dysfunction (ED) is a common impairment among older men, and the prevalence rates increase sharply after age of 60 years. Most studies have focused on the prevalence rate or dangerous factors. The aim of this study was to investigate the basic epidemiologic data about ED patients with different ED courses. The purpose of this research was to understand the therapeutic effect of phosphodiesterase type 5 inhibitor (PDE5-I) and see how and why the ED course impact the progress of ED and the therapeutic effect of PDE5-I treatment.
METHODS: From June 2008 to June 2009, 4252 questionnaires (Quality of Erection Questionnaire, QEQ) were gathered from 46 centers by urology or andrology doctors all around China. Patients with ED (age ≥ 20 years) filled in first half of the questionnaires when they came for the first time, and then completed the second half 4 weeks after PDE5-I therapy.
RESULTS: ED courses of most patients were less than 5 years (< 5 years, 74.0%; 5 - 10 years 20.8%; > 10 years, 5.2%). As ED course increasing, the incidence of the risk factors of ED, such as smoking, drinking, hypertension, diabetes, heart disease and hyperlipidemia also increase (P ≤ 0.01). PDE5-I was effective in improving the quality of sexual activities (P ≤ 0.01). Administration of PDE5-I improves satisfaction, enjoyment and frequency of sexual activities. The longer the ED course, the worse the therapeutic effect (< 5 years, 96.1%; 5 - 10 years, 94.9%; > 10 years, 89.0%) (P ≤ 0.01).
CONCLUSIONS: The ED course greatly affected the therapeutic effect of PDE5-1, the patients with ED should consult doctor at early stage of the disease. Administration of PDE5-I effectively improves the penile erection and the quality of sexual life of the patients hence should be considered as first-line medicine in the treatment of ED.
Authors:
De-Feng Liu; Hui Jiang; Kai Hong; Lian-Ming Zhao; Wen-Hao Tang; Lu-Lin Ma
Related Documents :
1656676 - Benefit of intravenous essential amino-acids in catabolic patients on chronic maintenan...
22481476 - Long-term results of photodynamic therapy for subfoveal choroidal neovascularization wi...
3436656 - Super obesity and gastric reduction procedures.
17704886 - Laparoscopic treatment of type 2 diabetes mellitus for patients with a body mass index ...
755316 - Effect of antibiotics on the results and complications or thoracic operations. par ii.
21613626 - Endocanalicular, high-pressure balloon catheter, endoscopic dacryocystorhinostomy: a ra...
Publication Detail:
Type:  Journal Article    
Journal Detail:
Title:  Chinese medical journal     Volume:  123     ISSN:  0366-6999     ISO Abbreviation:  Chin. Med. J.     Publication Date:  2010 Nov 
Date Detail:
Created Date:  2010-12-17     Completed Date:  -     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  7513795     Medline TA:  Chin Med J (Engl)     Country:  China    
Other Details:
Languages:  eng     Pagination:  3258-61     Citation Subset:  IM    
Affiliation:
Department of Urology, Peking University Third Hospital, Beijing 100191, China.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Clinical and prognostic characteristics of 573 cases of primary Sjögren's syndrome.
Next Document:  Correlation of estrogen receptor alpha gene polymorphisms and bone mineral density in Chinese women ...